Have a personal or library account? Click to login
Neopterin, cellular adhesion molecules and myeolperoxidase in patients with stable and unstable angina pectoris Cover

Neopterin, cellular adhesion molecules and myeolperoxidase in patients with stable and unstable angina pectoris

Open Access
|Feb 2012

References

  1. Alam, S.E., Nasser, S.S., Fernainy, K.E., Habib, A.A., Badr, K.F. (2004). Cytokine imbalance in acute coronary syndrome. Curr. Opin. Pharmacol., 4(2), 166-170.10.1016/j.coph.2003.10.011
  2. Alberti, K.G., Zimet, P., Shaw, J. (2005). The metabolic syndrome — a new worldwide definition. Lancet, 366(9491), 1059-1062.
  3. Avanzas, P., Arroyo-Espliguero, R., Cosķn-Sales, J., Aldama, G., Pizzi, C., Quiles, J., Kaski, J.C. (2004a). Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart, 90, 847-852.10.1136/hrt.2003.015826
  4. Avanzas, P., Arroyo-Espliguero, R., Cosin-Sales, J., Quiles, J., Zouridakis, E., Kaski, J.C. (2004b). Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease. Amer. J. Cardiol., 93, 627-629.10.1016/j.amjcard.2003.11.035
  5. Avanzas, P., Arroyo-Espliguero, R., Quiles, J., Roy, D., Kaski, J.C. (2005). Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris. Eur. Heart. J., 26(5), 457-463.10.1093/eurheartj/ehi111
  6. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., Hamm C.Q., CAPTURE Investigators. (2003). Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation, 108, 1440-1445.10.1161/01.CIR.0000090690.67322.51
  7. Balogh A., Mittermayr M., Schlager A., Balogh D., Schobersberger W., Fuchs D., Margreiter J. (2005). Mechanism of neopterin-induced myocardial dysfunction in the isolated perfused rat heart. Biochim. Biophys. Acta, 1724(1-2), 17-22.10.1016/j.bbagen.2005.04.006
  8. Blankenberg, S., Barbaux, S., Tiret, L. (2003) Adhesion molecules and atherosclerosis. Atherosclerosis, 170, 191-203.10.1016/S0021-9150(03)00097-2
  9. Blankenberg, S., Rupprecht, H.J., Bickel, C. (2001). Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation, 104, 1336-1342.10.1161/hc3701.09594911560847
  10. Braunwald, E. (1989). Unstable angina: A classification. Circulation, 80, 410-414.10.1161/01.CIR.80.2.4102752565
  11. Brennan M.L., Penn M.S., van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean, E.S., Topol, E.J., Nissen, S.E., Hazen, S.L. (2003) Prognostic value of myeloperoxydase in patients with chest pain. N. Engl. J. Med., 349, 1595-1604.
  12. Burke, A.P., Tracy, R.P., Kolodgie, F., Malcom, G.T., Zieske, A., Kutys, R., Pestaner, J., Smialek, J., Virmani, R. (2002). Elevated C-reactive protein values and atherosclerosis in sudden coronary death: Association with different pathologies. Circulation, 105, 2019-2023.10.1161/01.CIR.0000015507.29953.38
  13. Cirillo, P., Pacileo, M., de Rosa, S., Calabrņ, P., Gargiulo, A., Angri, V., Granato-Corigliano, F., Fiorentino, I., Prevete, N., de Palma, R., Mauro, C., Leonardi, A., Chiariello, M. (2006). Neopterin induces pro-atherothrombotic phenotype in human coronary endothelial cells. J. Thromb. Haemost., 4(10), 2248-2255.10.1111/j.1538-7836.2006.02125.x16842491
  14. Constans, J., Conri, C. (2006). Circulating markers of endothelial function in cardiovascular disease. Clin. Chim. Acta, 368(1-2), 33-47.10.1016/j.cca.2005.12.03016530177
  15. Eschen, O., Christensen, J.H., Toft, E., Schmidt, E.B. (2005). Soluble adhesion molecules and marine n-3 fatty acids in patients referred for coronary angiography. Atherosclerosis, 180(2), 327-331.10.1016/j.atherosclerosis.2004.12.00615910859
  16. Estévez-Loureiro, R., Recio-Mayoral, A., Sieira-Rodrķguez-Moret, J.A., Trallero-Araguis, E., Kaski, J.C. (2009). Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. Atherosclerosis, 207(2), 514-518.10.1016/j.atherosclerosis.2009.04.03219577753
  17. Gonzalez, M.A., Selwyn, A.P. (2003). Endothelial function, inflammation, and prognosis in cardiovascular disease. Amer. J. Med., 115(Suppl. 8A), 99S-106S.10.1016/j.amjmed.2003.09.01614678874
  18. Heslop, C.L., Frohlich, J.J., Hill, J.S. (2010). Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascular mortality after coronary angiography. J. Amer. Coll. Cardiol., 55(11), 1102-1109.10.1016/j.jacc.2009.11.05020223364
  19. Huber, C., Batchelor, J.R., Fuchs, D., Hausen, A., Lang, A., Niederwieser, D., Reibnegger, G., Swetly, P., Troppmair, J., Wachter, H. (1984) Immune response-associated production of neopterin: Release from macrophages primarily under control of interferon-gamma. J. Exp. Med., 160, 310-316.10.1084/jem.160.1.31021874256429267
  20. Hwang, S.J, Ballantyne, C.M., Sharrett, A.R, (1997). Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: The atherosclerosis risk in communities (ARIC) study. Circulation, 96, 4219-4225.10.1161/01.CIR.96.12.4219
  21. Kaski, J.C., Consuegra-Sanchez, L., Fernandez-Berges, D.J., Cruz-Fernandez, J.M., Garcia-Moll, X., Marrugat, J., Mostaza, J., Toro-Cebada, R., Gonzilez-Juanatey, J.R., Guzmin-Martķnez, G.; SIESTA Investigators. (2008). Elevated serum neopterin levels and adverse cardiac events at 6 months follow-up in Mediterranean patients with non-ST-segment elevation acute coronary syndrome. Atherosclerosis, 201(1), 176-183.10.1016/j.atherosclerosis.2008.01.00918336825
  22. Kressel, G., Trunz, B., Bub, A., Hülsmann, O. (2009). Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk. Atherosclerosis, 202(1). 263-271.10.1016/j.atherosclerosis.2008.04.01218501910
  23. Miwa, K., Igawa, A., Inoue, H. (1997). Soluble E-selectin, ICAM-1 and VCAM-1 levels in systemic and coronary circulation in patients with variant angina. Cardiovasc. Res., 36, 37-44.10.1016/S0008-6363(97)00143-0
  24. Mizia-Stec, K., Zahorska-Markiewicz, B., Mandecki, T., Janowska, J., Szulc, A., Jastrzebska-Maj, E. (2002). Serum levels of selected adhesion molecules in patients with coronary artery disease. Int. J. Cardiol., 83(2), 143-150.10.1016/S0167-5273(02)00032-3
  25. Murr, C., Winklhofer-Roob, B.M., Schroecksnadel, K., Maritschnegg, M., Mangge, H., Böhm, B.O., Winkelmann, B.R., März, W., Fuchs, D. (2009). Inverse association between serum concentrations of neopterin and antioxidants in patients with and without angiographic coronary artery disease. Atherosclerosis, 202(2), 543-549.10.1016/j.atherosclerosis.2008.04.047
  26. Nicholls, S., Hazen, S. (2005). Myeloperoxidase and cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 25, 1102-1111.10.1161/01.ATV.0000163262.83456.6d
  27. Peter, K., Nawroth, P., Conradt, C. (1997). Circulating vascular cell adhesion molecule-1 correlates with the extent of human atherosclerosis in contrast to circulating intercellular adhesion molecule-1, E-selectin, P-selectin, and thrombomodulin. Arterioscler. Thromb. Vasc. Biol., 17, 505-512.10.1161/01.ATV.17.3.505
  28. Pigo, R., Dillon, L.P., Hemingway, I.H., Gearing, A.J. (1992). Soluble forms of Eselectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem. Biophys. Res. Commun., 187, 584-589.10.1016/0006-291X(92)91234-H
  29. Ridker, P.M., Hennekens, C.H., Roitman-Johnson, B., Stampfer, M.J., Allen, J. (1998). Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet, 351, 88-92.10.1016/S0140-6736(97)09032-6
  30. Roman, R.M., Camargo, P.V., Borges, F.K., Rossini, A.P., Polanczyk, C.A. (2010) Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery Dis., 21(3), 129-136.10.1097/MCA.0b013e328333f50d20305551
  31. Roman, R.M., Camargo, P.V., Borges, F.K., Rossini, A.P., Polanczyk, C.A. (2010). Prognostic value of myeloperoxidase in coronary artery disease: Comparison of unstable and stable angina patients. Coron. Artery. Dis., 21(3), 129-136.10.1097/MCA.0b013e328333f50d
  32. Rudolph, V., Goldmann B.U., Bös C., Rudolph T.K., Klinke A., Friedrichs K., Lau D., Wegscheider K., Haddad, M., Meinertz, T., Baldus, S. (2010). Diagnostic value of MPO plasma levels in patients admitted for suspected myocardial infarction. Int. J. Cardiol., [Epub ahead of print].
  33. Ruotsalainen, E., Vauhkonen, I., Salmenniemi, U., Pihlajamäki, J. (2008). Markers of endothelial dysfunction and low-grade inflammation are associated in the offspring of type 2 diabetic subjects. Atherosclerosis, 197(1), 271-277.10.1016/j.atherosclerosis.2007.04.02117560580
  34. Schindhelm, R.K., van der Zwan, LP., Teerlink T., Scheffer. P.G. (2009). Myeloperoxidase: A useful biomarker for cardiovascular disease risk stratification? Clin Chem., 55(8), 1462-1470.10.1373/clinchem.2009.126029
  35. Schumacher, M., Halwachs, G., Tatzber, F., Fruhwald, F.M., Zweiker, R., Watzinger, N. (1997). Increased neopterin in patients with chronic and acute coronary syndromes. J. Amer. Coll. Cardiol., 30, 703-707.10.1016/S0735-1097(97)00172-1
  36. van der Meer, I., de Maat, M.P., Bots, M.L. (2002). Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis: The Rotterdam study. Arterioscler. Thromb. Vasc. Biol., 22, 838-842.10.1161/01.ATV.0000016249.96529.B8
  37. Wirleitner, B., Baier-Bitterlich, G., Hoffmann, G., Schobersberger, W., Wachter, H., Fuchs, D. (1997) Neopterin derivatives to activate NF-kappa B. Free Radic. Biol. Med., 23, 177-179.
  38. Zakynthinos, E., Pappa, N. (2009). Inflammatory biomarkers in coronary artery disease. J. Cardiol., 53(3), 317-333.10.1016/j.jjcc.2008.12.00719477372
  39. Zhang, R., Brennan, M.L., Fu, X., Aviles, R.J., Pearce, G.L., Penn, M.S., Topol E.J., Sprecher, D.L., Hazen, S.L. (2001). Association between myeloperoxidase levels and risk of coronary artery disease. J. Amer. Med. Assoc., 286, 2136-2142.10.1001/jama.286.17.213611694155
  40. Zouridakis, E., Avanzas, P., Arroyo-Espliguero, R., Fredericks, S., Kaski, J.C. (2004). Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation, 110, 1747-1753.10.1161/01.CIR.0000142664.18739.9215381646
DOI: https://doi.org/10.2478/v10046-011-0023-3 | Journal eISSN: 2255-890X | Journal ISSN: 1407-009X
Language: English
Page range: 87 - 93
Published on: Feb 15, 2012
Published by: Latvian Academy of Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 6 issues per year

© 2012 Pēteris Tretjakovs, Antra Jurka, Inga Bormane, Indra Miķelsone, Dace Reihmane, Gita Krieviņa, Iveta Marksa, Karlīna Elksne, Jurijs Verbovenko, Guntis Bahs, published by Latvian Academy of Sciences
This work is licensed under the Creative Commons License.

Volume 65 (2011): Issue 3-4 (August 2011)